Edition:
United Kingdom

Hubei Jumpcan Pharmaceutical Co Ltd (600566.SS)

600566.SS on Shanghai Stock Exchange

36.87CNY
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
¥36.87
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,453,887
52-wk High
¥44.00
52-wk Low
¥28.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 1,405.36 0.360
Mar '17 1,404.81 0.359
FY 2016 Dec '16 1,171.42 0.319
Sep '16 1,152.67 0.292
Jun '16 1,197.19 0.292
Mar '16 1,156.62 0.268
FY 2015 Dec '15 951.38 0.240
Sep '15 943.74 0.215
Jun '15 968.25 0.220
Mar '15 904.47 0.204
 
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-17 6 5,759.86 5,839.81 5,687.00 5,856.45
Year Ending Dec-18 6 6,949.96 7,167.62 6,733.00 7,169.20
Earnings (per share)
Year Ending Dec-17 6 1.49 1.53 1.38 1.39
Year Ending Dec-18 6 1.84 1.99 1.60 1.73
Sales and Profit Figures in China Yuan Renminbi (CNY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 27.73 31.14 32.93
P/E High - Last 5 Yrs. 31.48 40.91 45.62
P/E Low - Last 5 Yrs. 17.01 23.80 24.34
Beta 0.47 0.90 0.88
Price to Sales (TTM) 5.81 3.93 5.40
Price to Book (MRQ) 8.29 4.81 5.38
Price to Tangible Book (MRQ) 9.32 5.53 6.78
Price to Cash Flow (TTM) -- 23.04 23.45
% Owned Institutions -- 0.88 1.40

Dividends

  Company industry sector
Dividend Yield 1.98 1.56 1.50
Dividend Yield - 5 Year Avg 1.74 1.57 1.52
Dividend 5 Year Growth Rate 135.87 4.33 5.17
Payout Ratio(TTM) 54.95 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 17.39 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago 20.84 4.66 5.38
Sales - 5 Yr. Growth Rate 81.05 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 23.04 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago 31.02 -- --
EPS - 5 Yr. Growth Rate 82.83 9.86 10.79
Capital Spending - 5 Yr. Growth Rate 39.73 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.69 2.11 2.18
Current Ratio (MRQ) 1.84 2.88 2.98
LT Debt to Equity (MRQ) 0.00 9.47 11.56
Total Debt to Equity (MRQ) 3.15 13.43 15.81
Interest Coverage (TTM) -- 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 83.25 55.14 54.83
Gross Margin - 5 Yr. Avg. 84.42 52.29 52.40
EBITD Margin (TTM) 23.40 -- --
EBITD - 5 Yr. Avg 21.66 18.46 15.24
Operating Margin (TTM) 23.47 14.50 7.76
Operating Margin - 5 Yr. Avg. 19.31 14.42 10.75
Pre-Tax Margin (TTM) 24.39 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. 20.53 14.74 11.17
Net Profit Margin (TTM) 20.97 11.22 4.88
Net Profit Margin - 5 Yr. Avg. 17.58 11.08 7.47
Effective Tax Rate (TTM) 14.03 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. 14.39 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,003,176 953,213,828 864,673,362
Net Income/Employee (TTM) 210,358 112,151,383 101,717,513
Receivable Turnover (TTM) 3.47 5.60 5.76
Inventory Turnover (TTM) 4.77 2.58 3.34
Asset Turnover (TTM) 1.08 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 22.73 11.42 11.00
Return on Assets - 5 Yr. Avg. 20.57 13.00 12.43
Return on Investment (TTM) 31.21 14.86 14.46
Return on Investment - 5 Yr. Avg. 30.33 17.00 16.28
Return on Equity (TTM) 31.81 16.28 16.05
Return on Equity - 5 Yr. Avg. 31.05 18.03 17.51
  1 Year 3 Year 5 Year
Sales % 24.15 24.10 81.05
EPS (TTM) % 33.17 21.07 82.83
Dividend % 4.29 -- 135.87
Note: Units in Millions of US Dollars

Performance for Hubei Jumpcan Pharmaceutical Co Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.63%
# of Holders: 45
Total Shares Held: 61,733,904
3 Mo. Net Change: -5,513,703
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 6
# Reduced Positions: 5
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.